Clinical Trial Update: A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP [NA]

View source ↗

Summary

A completed clinical trial evaluated the LMA Gastro dual-channel supraglottic airway device for oxygenation during ERCP procedures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Gallbladder Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• LMA Gastro

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Bile Duct Carcinoma, Gallbladder Carcinoma | NA | Status: COMPLETED | Results posted: 2024-11-06